Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 2Urinary Tract Infections 1Non-Muscle Invasive Bladder Neoplasms 1Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1Cystitis 1

Interventions

tislelizumab 1lornoxicam 1Patient Discharge 1Ofloxacin 1Mitomycin 1Epirubicin 1Drainage 1Doxorubicin 1BCG Vaccine 1Accelerometry 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Non-Muscle Invasive Bladder Neoplasms × Ofloxacin × Clear all
NCT03038321 2017-05-23

Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects?

Mansoura University

Phase 4 Unknown
150 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Cystitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡